Comparison of efficacy and safety of cyclosporine (CsA) discontinuation with introduction of sirolimus (SRL) at week 12 to standard strategy in renal transplant recipients receiving mycophenolate mofetil (MMF).

被引：0
|
作者：
Lebranchu, Y. [1 ]
Etienne, I. [1 ]
Touchard, G. [1 ]
Thervet, E. [1 ]
Westeel, P. F. [1 ]
Toupance, O. [1 ]
de Ligny, B. Hurault [1 ]
Moulin, B. [1 ]
Frouget, T. [1 ]
Le Meur, Y. [1 ]
Glotz, D. [1 ]
Mignon, F. [1 ]
Deteix, P. [1 ]
Subra, J. F. [1 ]
Bayle, F. [1 ]
Noel, C. [1 ]
Hayem, C. [1 ]
Girardot-Seguin, S. [1 ]
Buehler, M. [1 ]
机构：
[1] CHU Bretonneau, Tours, France
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2007年 / 7卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
53
引用
收藏
页码：160 / 160
页数：1
相关论文
共 36 条
  • [21] 12 month report of a 3 arm multicenter comparison of tacrolimus (TAC), MMF or TAC/sirolimus(SRL) and steroids vs cyclosporine microemulsion(CYA), MMF and steroids in de novo cardiac transplant recipients
    Kobashigawa, J. W.
    Miller, L. W.
    Felker, G. M.
    Russel, S. D.
    Ewald, G. A.
    Zucker, M.
    Goldberg, L.
    Eisen, H. J.
    Rayburn, B. K.
    Wagoner, L. E.
    Philbin, E.
    Pereira, N.
    Czerska, B.
    Kormos, R. L.
    Weston, M.
    Conte, J.
    Hosenpud, J.
    Aaronson, K.
    Hill, J.
    Copeland, J. G.
    Czer, L.
    Anderson, A.
    Dec, G. W.
    Torre-Amione, G.
    Yancy, C. W.
    Vega, J. D.
    Jarcho, J. A.
    Mancini, D.
    Bhat, G.
    First, R.
    Fitzsimmons, W.
    Tolzman, D.
    Salm, K.
    Gao, J.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2005, 24 (02): : S61 - S62
  • [22] A randomized, open-label study to compare the safety and efficacy of two different sirolimus (SRL) regimens with a tacrolimus (TAC) and mycophenolate mofetil (MMF) regimen in de novo renal allograft recipients: Renal function results from the Orion study
    Flechner, Stuart
    Glyda, Maciej
    Steinberg, Steven
    Harler, Mary Beth
    TRANSPLANT INTERNATIONAL, 2007, 20 : 25 - 25
  • [23] The pharmacokinetics of mycophenolate mofetil in renal transplant recipients receiving standard-dose or low-dose cyclosporine, low-dose tacrolimus or low-dose sirolimus: the Symphony pharmacokinetic substudy
    Grinyo, Josep M.
    Ekberg, Henrik
    Mamelok, Richard D.
    Oppenheimer, Federico
    Sanchez-Plumed, Jaime
    Angel Gentil, Miguel
    Hernandez, Domingo
    Kuypers, Dirk R.
    Brunet, Merce
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2009, 24 (07) : 2269 - 2276
  • [24] A randomized, open-label study to compare the safety and efficacy of two different sirolimus (SRL) regimens with a tacrolimus (Tac) and mycophenolate mofetil (MMF) regimen in de novo renal allograft recipients: Renal function results from the ORION study.
    Flechner, Stuart
    Glyda, Maciej
    Steinberg, Steven
    Harler, M. B.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 : 440 - 440
  • [25] Long-term safety and efficacy after conversion of maintenance renal transplant recipients from mycophenolate mofetil (MMF) to enteric-coated mycophenolate sodium (EC-MPA, myfortic®)
    Budde, K.
    Knoll, G.
    Curtis, J.
    Chan, L.
    Pohanka, E.
    Gentil, M.
    Seifu, Y.
    Marrast, A. -C.
    Neumayer, H. -H.
    CLINICAL NEPHROLOGY, 2006, 66 (02) : 103 - 111
  • [26] Impact on Renal Function of Early Conversion at 3 Months from Cyclosporine (CsA) to Sirolimus (SRL) in Association with Mycophenolate Mofetil (MMF) in Kidney Transplantation: 30-Months Follow up of a Multicenter Randomized Controlled Trial: The Concept Study.
    Lebranchu, Y.
    Toupance, O.
    Touchard, G.
    Thervet, E.
    Etienne, I.
    Mazouz, H.
    de Ligny, B. Hurault
    Moulin, B.
    Rerolle, J. P.
    Frouget, T.
    Glotz, D.
    Randoux, C.
    Bayle, F.
    Heng, A. E.
    Allano, F.
    Buchler, M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 : 260 - 260
  • [27] A randomized, open-label study to compare the safety and efficacy of two different sirolimus (SRL) regimens with tacrolimus (TAC) plus mycophenolate mofetil (MMF) in De Novo renal allograft recipients:: Preliminary 2-year safety results from the ORION trial
    Flechner, Stuart M.
    Cockfield, Sandra
    Grinyo, Josep
    Russ, Graeme
    Wissing, K. Martin
    Legendre, Christophe
    Copley, J. Brian
    AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 582 - 582
  • [28] A randomized, open-label study to compare the efficacy and safety of two different sirolimus (SRL) regimens with tacrolimus (TAC) plus mycophenolate mofetil (MMF) in de novo renal allograft recipients: Preliminary 2-year efficacy results from the ORION trial
    Flechner, Stuart M.
    Cockfield, Sandra
    Grinyo, Josep
    Russ, Graeme
    Wissing, K. Martin
    Legendre, Christophe
    Copley, J. Brian
    AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 254 - 254
  • [29] A randomized, prospective, multicenter comparison of tacrolimus, mycophenolate mofetil (MMF) and steroids vs. cyclosporine (modified USP), MMF and steroids vs. tacrolimus, sirolimus and steroids in de novo cardiac transplant recipients - 6 month report.
    Russell, SD
    Kobashigawa, JA
    Miller, LW
    Ewald, GA
    Zucker, M
    Goldberg, LR
    Eisen, HJ
    Salm, KA
    Washington, R
    Fitzsimmons, WE
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 282 - 282
  • [30] A randomized, open-label study to compare the safety and efficacy of two different sirolimus (SRL) regimens with a tacrolimus (TAC) and mycophenolate mofetil regimen (MMF) in De novo renal allograft recipients: Acute rejection and graft survival results from the orion study
    Flechner, Stuart
    Glyda, Maciej
    Steinberg, Steven
    Harler, Mary Beth
    TRANSPLANT INTERNATIONAL, 2007, 20 : 209 - 210
1234